Clinilabs: Early Phase and Specialty Clinical Drug Development
 
 

Insomnia Research

Study 1

Having difficulty falling asleep and staying asleep?

If so, Clinilabs is currently conducting a clinical research study of an investigational medication for insomnia.

To Qualify Participants Must:

  • Be between the ages of 18 and 65
  • Typically take 30 minutes or more to fall asleep and spend 45 minutes or more awake at night
  • Be in general good health

Eligible Participants May Receive:

  • Financial compensation up to $1575.
  • Study-related medical exams, investigational medication or placebo, and sleep assessments at no cost.

Contact Us Today!
• (212) 994.4567
participate@clinilabs.com
www.clinilabs.com/insomnia
• 423 West 55th Street, 4th Floor, NYC (Between 9th and 10th avenues)

Health insurance is not required.

To complete our online questionnaire CLICK HERE or call 212.994.4567 to speak with a clinical research recruiter.

Study 2

Tired of sleepless nights?      

Do you have a hard time falling asleep at night?  If so, Clinilabs is currently conducting a clinical research study of an investigational medication for insomnia.

To Qualify Participants Must:

  • Be between the ages of 18-64
  • Have a diagnoses or symptoms of insomnia
  • Be in general good health

Eligible Participants May Receive:

  • Financial compensation up to $1300.
  • Study-related medical exams, investigational medication or placebo, and sleep assessments at no cost.

Clinilabs is also enrolling healthy volunteers in this study. If you are between the ages of 18-64 and are in general good health call today!

Contact Us Today!
• (212) 994.4567
participate@clinilabs.com
www.clinilabs.com/insomnia
• 423 West 55th Street, 4th Floor, NYC (Between 9th and 10th avenues)

Health insurance is not required.

To complete our online questionnaire CLICK HERE or call 212.994.4567 to speak with a clinical research recruiter.


 
 




 

 

 

 






 

 

 

 

 

 

 

 


 
Join the Conversation
Facebook
Twitter
YouTube  
Bookmark and Share